GEN Exclusives

More »

Best of the Web

More »
Sep 01, 2008 (Vol. 28, No. 15)

Angiogenesis and Cancer Control

URL:www.moffitt.org/moffittapps/ccj//v6n5/article2.htm
  • Organization
  • A little light
Cells in developing tumors, the story goes, require more oxygen than normal cells due to their higher metabolic rate. Indeed, it is thought that the growth of blood vessels toward tumor cells is an important step in their development. It is no surprise, therefore, that drugs suppressing angiogenesis are readily sought for the treatment of cancers. The H. Lee Moffitt Cancer Center and Research Institute hosts this rather spotty collection of information on the subject of angiogenesis and cancer control. To find the goods, you’ll need to look around. The Search Clinical Trials database is the main offering here with options for selecting on the basis of disease type, drug, therapy, and phase of the disease. Most of the other links at the site are more aimed at general info or about the institute itself.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?